Information Provided By:
Fly News Breaks for February 28, 2017
AYR, CSX, HSY, ESPR, X
Feb 28, 2017 | 10:22 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. U.S. Steel (X) upgraded to Outperform from Market Perform at Cowen with analyst Novid Rassouli saying he believes the company will be the primary beneficiary of the increasing steel intensity. Rassouli noted that the downturn in oil prices has masked the roughly 40% increase in monthly steel usage over the last six years but with the normalization of inventory and increase in self-help initiatives, the company has upside potential. Rassouli raised his price target to $60 from $36 on U.S. Steel shares. 2. Esperion (ESPR) upgraded to Buy from Neutral at Citi. 3. Hershey (HSY) upgraded to Hold from Sell at Societe Generale with analyst Warren Ackerman saying there is limited downside to growth from here and a more consumer-oriented portfolio should drive LFL growth to a a longer-term range of 3-4%. He also expects increased focus on operating efficiencies and target to drive margins up by 200bp by 2020. 4. CSX (CSX) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra citing his conversation with Mantle Ridge CEO Paul Hilal regarding the likely timing of potential operational initiatives, Mehrotra increased his "blue sky" target on CSX to $60 from $48. The entirety of potential profit improvements may be achieved inside of three years, versus a previous assumption of five years, Mehrotra tells investors in a research note. The analyst's "blue sky" scenario has Hunter Harrison and Paul Hilal running CSX. 5. Aircastle (AYR) upgraded to Neutral from Underperform at BofA/Merrill with the firm citing decreased exposure to freight aircraft. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For X;ESPR;HSY;CSX;AYR From the Last 2 Days
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
CSX
Mar 27, 2024 | 08:04 EDT
JPMorgan analyst Brian Ossenbeck anticipates intermodal shipments will divert away from the Port of Baltimore following the Francis Scott Key bridge collapse to other Eastern ports. The impact for rail auto volumes appears minimal given the activity at the port is primarily contained to local markets served by truck, the analyst tells investors in a research note. The firm thinks the biggest negative impact will be on export coal volume for CSX which is shipped from the Curtis Bay terminal in the area while Norfolk could pick up some volume if it is diverted to Hampton Road. The ultimate impact will depend on how quickly the port resumes operations and at this point the U.S. government has already made a statement supporting the reconstruction, JPMorgan says.
HSY
Mar 26, 2024 | 08:13 EDT
Exane BNP Paribas downgraded Hershey to Neutral from Outperform with a $208 price target.